TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Industry Press release
Medicine Press release
Eisai: Release of Dementia Disease Awareness Videos for World Alzheimer's Day, September 21
Sep 21, 2023 11:26 JST
Eisai Co., Ltd. announced today on World Alzheimer's Day, that it has released a dementia awareness video, "Life Goes On 2023: Two Memories, One Story", on its dementia information website "Sodan.e-65" and YouTube, which are intended to deepen the understanding of dementia.
More info..
Fujitsu and Baptist Health South Florida transform operating room scheduling with newly launched solution to boost utilization rates and the financial health of the surgical discipline
Sep 14, 2023 09:33 JST
Fujitsu today announced the launch of an innovative solution to its Uvance Healthy Living portfolio to transform surgical capacity utilization with a new approach in the market by targeting the root cause of surgical block time inefficiencies.
More info..
NEC selected by AMED for design of a universal vaccine that is effective against influenza virus strains
Sep 14, 2023 09:09 JST
NEC Corporation has been selected to participate in a vaccine/new modality research and development project beginning in FY2023. NEC was selected following its submission of a research project titled "Development of universal vaccine design technology using computational science" in response to a public call for proposals by the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA).
More info..
Eisai Establishes Theoria Technologies Co., Ltd., A New Digital Business Company To Build A Dementia Ecosystem
Sep 12, 2023 18:05 JST
Eisai Co., Ltd. announced today that it has established a digital business company Theoria technologies Co., Ltd. ("Theoria technologies") which will accelerate the development of a dementia ecosystem. Theoria technologies is a wholly owned subsidiary of Eisai.
More info..
BostonGene, NEC and JIP Form Joint Venture in Japan
Aug 24, 2023 09:11 JST
BostonGene, a leading provider of AI-based molecular and immune profiling solutions, NEC Corporation, a leader in IT, network and AI technologies, and Japan Industrial Partners, a leading Tokyo-based private equity firm, today announced the formation of BostonGene Japan Inc., a Tokyo-based joint venture aimed at advancing personalized medicine and dramatically improving patient outcomes.
More info..
Nagasaki University and NEC OncoImmunity Collaborate to Design Universal Vaccines Targeting Tropical Infectious Diseases
Aug 21, 2023 09:09 JST
Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, have announced that they will collaborate to use NOI's AI platform to design universal vaccines against highly pathogenic and tropical infectious diseases.
More info..
CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer
Aug 08, 2023 15:00 JST
CanariaBio, a KOSDAQ-listed and a leading late-stage biotechnology company, announces the successful enrollment completion of a Phase 2 study of Oregovomab in combination with niraparib, GSK's poly (ADP-ribose) polymerase (PARP) inhibitor, for treatment of patients with platinum-sensitive recurrent ovarian cancer.
More info..
CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer
Aug 08, 2023 15:00 JST
CanariaBio, a KOSDAQ-listed and a leading late-stage biotechnology company, announces the successful enrollment completion of a Phase 2 study of Oregovomab in combination with niraparib, GSK's poly (ADP-ribose) polymerase (PARP) inhibitor, for treatment of patients with platinum-sensitive recurrent ovarian cancer.
More info..
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells
Aug 08, 2023 12:39 JST
Our paper describing the results of this study was published on August 6, 2023 in the "Journal for ImmunoTherapy of Cancer," which is the official journal of the Society of Immunotherapy of Cancer (SITC) in the United States.
More info..
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells
Aug 08, 2023 12:39 JST
Our paper describing the results of this study was published on August 6, 2023 in the "Journal for ImmunoTherapy of Cancer," which is the official journal of the Society of Immunotherapy of Cancer (SITC) in the United States.
More info..
1
2
3
>>
Last
Releases By Industry
Business
Communications
CryptoCurrency
Financial
Industrial
Lifestyle
Medicine
Sustainablity
Technology